Silo Wellness, a publicly traded company listed on the CSE, acquired 100% of the shares of Dyscovry Science Ltd. , a private company incorporated under the CBCA. Dyscovry is a Toronto-based biotechnology company focused on biosynthetic manufacturing of psilocybin and its derivatives targeting a physiological condition, irritable bowel syndrome.
Bankruptcy and Insolvency
With over thirty years managing commercial and family disputes, we are well positioned to give practical and sophisticated advice in managing claims against insolvent debtors and trustees in bankruptcy on a range of commercial and personal bankruptcy issues.
Some of our most noteworthy cases involve commencing and responding to appeals of trustees’ decisions, removal and appointment of trustees and advising on a host of priority matters.
We also have a wide range of experience in identifying claims that may survive bankruptcy and can be successfully commenced and in dealing with non-compliant debtors.
However, what is often most important is advice. Planning ahead and developing strategies for trustees, creditors and debtors transcends understanding the technical intricacies of bankruptcy law. It requires experience and strategic thinking, which are critical to obtaining controlled and optimal results for our clients.